• Info
  • Significant Ownership

Significant Ownership of BIOTECHNOLOGY VALUE FUND L P

Signature - Title
/s/ Mark N. Lampert - Mark N. Lampert, Authorized Signatory
Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BIOTECHNOLOGY VALUE FUND L P.

Notify me when BIOTECHNOLOGY VALUE FUND L P files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of BIOTECHNOLOGY VALUE FUND L P

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MLTX MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share 28% $141,616,706 19,751,284 BVF PARTNERS L P/IL 06 Nov 2025
XOMA XOMA Royalty Corp Common Stock, $0.0075 par value 22% $63,747,357 -$9,664,913 2,590,303 -13% BVF GP HOLDINGS LLC 16 May 2025
GHRS GH Research PLC Ordinary Shares, nominal value $0.025 per share 14% $84,128,095 8,827,712 BVF PARTNERS L P/IL 31 Mar 2025
XNCR Xencor Inc Common Stock, par value $0.01 per share 10% $109,217,253 +$38,495,142 7,133,720 +54% BVF PARTNERS L P/IL 31 Dec 2025
KURA Kura Oncology, Inc. Common Stock, par value $0.0001 per share 10% $76,791,609 +$24,465,506 8,677,018 +47% BVF PARTNERS L P/IL 30 Sep 2025
CGEM Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share 10% $64,748,182 5,918,481 BVF PARTNERS L P/IL 31 Dec 2025
FDMT 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share 10% $45,959,629 +$9,546,222 5,847,281 +26% BVF PARTNERS L P/IL 31 Dec 2025
AVTX Avalo Therapeutics, Inc. Common Stock, $0.001 par value per share 10% $32,277,156 +$7,561,497 1,904,257 +31% BVF PARTNERS L P/IL 31 Dec 2025
CBIO CRESCENT BIOPHARMA, INC. Ordinary Shares, $0.001 par value per share 10% $18,736,150 1,387,863 BVF PARTNERS L P/IL 30 Jun 2025
TENX TENAX THERAPEUTICS, INC. Common Stock, $0.0001 par value per share 10% $11,561,410 768,200 BVF PARTNERS L P/IL 31 Dec 2025
TCRX TScan Therapeutics, Inc. Voting Common Stock, $0.0001 par value per share 10% $8,421,666 5,263,541 BVF PARTNERS L P/IL 31 Mar 2025
IMUX IMMUNIC, INC. Common Stock, $0.0001 par value 10% $8,314,667 +$2,345,708 13,630,601 +39% BVF PARTNERS L P/IL 12 Feb 2026
UNCY Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share 10% $7,439,864 1,417,117 BVF PARTNERS L P/IL 30 Jun 2025
VTGN Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share 10% $7,217,318 3,084,324 BVF PARTNERS L P/IL 31 Dec 2024
SABS SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value per share 9.1% $18,761,910 -$1,598,505 4,761,906 -7.9% BVF PARTNERS L P/IL 31 Dec 2025
IVVD Invivyd, Inc. Common Stock, $0.0001 par value per share 9% $64,323,000 +$24,003,000 25,525,000 +60% BVF PARTNERS L P/IL 31 Dec 2025
KYMR Kymera Therapeutics, Inc. Common Stock, $0.0001 par value per share 8.5% $436,311,906 6,867,809 BVF PARTNERS L P/IL 11 Dec 2025
IKNA Ikena Oncology, Inc. Common Stock, par value $0.001 per share 8.3% $4,246,958 4,006,564 BVF PARTNERS L P/IL 31 Dec 2024
STRO SUTRO BIOPHARMA, INC. Common Stock, $0.001 par value 7.6% $13,306,506 1,251,788 BVF PARTNERS L P/IL 10 Feb 2026
NKTR NEKTAR THERAPEUTICS Common Stock, $0.0001 par value 7.4% $32,978,662 1,276,595 BVF PARTNERS L P/IL 01 Jul 2025
IMA ImageneBio, Inc. Common Stock, par value $0.001 per share 7.2% $6,538,736 802,102 BVF PARTNERS L P/IL 30 Sep 2025
PVLA PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value per share 7.1% $88,331,614 -$30,366,571 879,009 -26% BVF PARTNERS L P/IL 31 Dec 2025
ELEV Elevation Oncology, Inc. Common Stock, par value $0.0001 per share 7% $1,642,800 4,440,000 BVF PARTNERS L P/IL 31 Mar 2025
GLUE Monte Rosa Therapeutics, Inc. Common Stock, $0.0001 par value per share 5.9% $92,022,905 -$43,763,662 3,835,886 -32% BVF PARTNERS L P/IL 31 Dec 2025
ZYME Zymeworks Inc. Common Stock, $0.00001 par value per share 5.2% $67,271,988 3,938,641 BVF PARTNERS L P/IL 30 Sep 2025
CMPX Compass Therapeutics, Inc. Common Stock, $0.0001 par value per share 5.1% $30,625,000 8,750,000 BVF PARTNERS L P/IL 22 Oct 2025
IVA Inventiva S.A. Ordinary Shares, nominal value (euro)0.01 per share 5% $39,714,931 +$4,251,111 9,569,863 +12% BVF PARTNERS L P/IL 17 Nov 2025
GPCR Structure Therapeutics Inc. Ordinary Shares, par value $0.0001 per share 4.9% $723,914,898 +$57,243,848 10,437,066 +8.6% BVF PARTNERS L P/IL 31 Dec 2025
CDTX Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.4% $113,871,586 -$21,545,460 1,189,165 -16% BVF PARTNERS L P/IL 15 Oct 2025
PTGX Protagonist Therapeutics, Inc Common Stock, $0.00001 par value per share 4.1% $170,121,650 -$43,187,804 2,560,916 -20% BVF PARTNERS L P/IL 30 Sep 2025
TYRA Tyra Biosciences, Inc. Common Stock, $0.0001 par value per share 4% $64,574,633 -$55,131,655 2,127,665 -46% BVF PARTNERS L P/IL 31 Dec 2025
XFOR X4 Pharmaceuticals, Inc Common Stock, par value $0.001 per share 3.9% $13,272,653 +$4,544,819 3,411,993 +52% BVF PARTNERS L P/IL 31 Dec 2025
VSTM Verastem, Inc. Common Stock, $0.0001 par value per share 3.9% $11,850,000 -$15,266,739 2,500,000 -56% BVF PARTNERS L P/IL 11 Aug 2025
SEPN Septerna, Inc. Common Stock, $0.001 par value per share 3.8% $42,813,056 -$66,562,509 1,720,782 -61% BVF PARTNERS L P/IL 31 Dec 2025
ETNB 89bio, Inc. Common Stock, par value $0.001 per share 3.6% $29,903,806 4,333,885 BVF PARTNERS L P/IL 31 Dec 2024
CTMX CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share 3.5% $17,250,001 -$17,250,001 5,769,231 -50% BVF PARTNERS L P/IL 03 Jul 2025
MIRM Mirum Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 3% $109,619,710 1,495,290 BVF PARTNERS L P/IL 30 Sep 2025
ENGN enGene Holdings Inc. Common Shares, no par value per share 1.8% $3,781,608 -$8,424,148 945,402 -69% BVF PARTNERS L P/IL 27 Jan 2025
CELC Celcuity Inc. Common Stock, $0.001 par value per share 1.6% $32,525,997 658,421 BVF PARTNERS L P/IL 30 Sep 2025
NLSP NewcelX Ltd. Common Shares, par value CHF 0.05 0.6% 28,732 BVF PARTNERS L P/IL 31 Oct 2025
FBRX Forte Biosciences, Inc. Common Stock, $0.001 par value 0.5% $980,250 -$8,674,080 65,350 -90% BVF PARTNERS L P/IL 30 Sep 2025
RPTX Repare Therapeutics Inc. Common Shares, no par value 0% $0 -$26,867,360 0 -100% BIOTECHNOLOGY VALUE FUND L P 28 Jan 2026
VIGL Vigil Neuroscience, Inc. Common Stock, par value $0.0001 per share 0% $0 -$38,112,725 0 -100% BIOTECHNOLOGY VALUE FUND L P 30 Jun 2025
ITOS iTeos Therapeutics, Inc. Common Stock, $0.001 par value per share 0% $0 -$31,641,750 0 -100% BIOTECHNOLOGY VALUE FUND L P 30 Jun 2025
THRD Third Harmonic Bio, Inc. Common Stock, par value $0.0001 per share 0% $0 0 BIOTECHNOLOGY VALUE FUND L P 14 Apr 2025
RAPT RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share 0% $0 -$303,393,560 0 -100% BIOTECHNOLOGY VALUE FUND L P 30 Sep 2025
EPIX ESSA Pharma Inc. Common Shares 0% $0 -$2,800,434 0 -100% BIOTECHNOLOGY VALUE FUND L P 09 Oct 2025
OVID Ovid Therapeutics Inc. Common Stock, par value $0.001 per share 0% $0 0 BIOTECHNOLOGY VALUE FUND L P 17 Jul 2025
VERV Verve Therapeutics, Inc. Common Stock, par value $0.001 per share 0% $0 0 BIOTECHNOLOGY VALUE FUND L P 30 Jun 2025
ALLK Allakos Inc. Common Stock, par value $0.001 0% $0 0 BIOTECHNOLOGY VALUE FUND L P 15 May 2025

Schedules 13D/G Reported by BIOTECHNOLOGY VALUE FUND L P:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.